Software to support breast cancer risk assessment

WRRisk is our clinical decision support software for breast cancer risk assessment.

How it Works


WRDensity was trained using deep learning based on over 600,000 images from Mallinckrodt Institute of Radiology, one of the world’s leading radiology research institutes.


Presented within the radiologist's existing workstation making relevant tissue density information available in context, WRDensity can deliver up to a 20% increase in productivity for users of the product. (insert footnote)


Radiologists can disagree with the product at any time and report the breast density based on their own appraisal without any additional clicks.

Details to Note

43% more consistent than radiologists when assessing patient exams across multiple years1

RIS/PACS Compatible

Trained on over 600K images from Mallinckrodt Institute of Radiology

WRRisk simplifies breast risk program maintenance by eliminating paper and automating many of the manual steps, from collecting forms to letter generation.

Equips patients and providers with the information they need. WRRisk Calculates 10-year and lifetime-risk as well as risk-based on runner-up density.

Built on top of existing well-established models for breast cancer risk.

Find out how our products can help your business drive compliance, improve patient outcomes, and increase revenue.


1  Whiterabbit data on file.

2  Artificial intelligence and consistency in patient care: a large-scale, longitudinal study of breast density assessment.

3 Whiterabbit data on file.

4 Holley, S., Cordoza, D., Matthews, T. P., & Gastounioti, A. (2022, December 3). Artificial intelligence and consistency in patient care: A large-scale, longitudinal study of breast density assessment [Conference Presentation].

1 Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K, for the Breast Cancer Surveillance Consortium. Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer. JAMA Oncol. 2017;3(9):1228–1236.

1 Eligible patient is defined as any woman who has a screening mammogram within the previous five years.

2 Moorman S, Pujara A, Sakala M, et al. Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening. American Journal of Roentgenology 2021 217:1, 40-47